Sheng Han

2.8k total citations
65 papers, 2.1k citations indexed

About

Sheng Han is a scholar working on Genetics, Molecular Biology and Cancer Research. According to data from OpenAlex, Sheng Han has authored 65 papers receiving a total of 2.1k indexed citations (citations by other indexed papers that have themselves been cited), including 23 papers in Genetics, 21 papers in Molecular Biology and 14 papers in Cancer Research. Recurrent topics in Sheng Han's work include Glioma Diagnosis and Treatment (23 papers), Meningioma and schwannoma management (9 papers) and MicroRNA in disease regulation (8 papers). Sheng Han is often cited by papers focused on Glioma Diagnosis and Treatment (23 papers), Meningioma and schwannoma management (9 papers) and MicroRNA in disease regulation (8 papers). Sheng Han collaborates with scholars based in China, United States and Australia. Sheng Han's co-authors include Anhua Wu, Xiufang Ren, Chuanbao Zhang, Wen Cheng, Zhonghua Li, Zixun Wang, Tao Jiang, Jinyun Dong, Yinde Huang and Y Liu and has published in prestigious journals such as PLoS ONE, Neurology and Cancer Research.

In The Last Decade

Sheng Han

60 papers receiving 2.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sheng Han China 23 846 711 587 548 485 65 2.1k
Wiesława Grajkowska Poland 27 1.9k 2.3× 1.0k 1.5× 406 0.7× 650 1.2× 258 0.5× 174 3.3k
Wenbin Ma China 30 679 0.8× 1.0k 1.5× 420 0.7× 375 0.7× 278 0.6× 175 2.7k
Alessandra Pattarozzi Italy 31 1.0k 1.2× 396 0.6× 815 1.4× 329 0.6× 323 0.7× 51 2.1k
Juxiang Chen China 29 1.5k 1.8× 457 0.6× 496 0.8× 864 1.6× 196 0.4× 76 2.6k
Helle Broholm Denmark 27 728 0.9× 936 1.3× 316 0.5× 428 0.8× 127 0.3× 91 2.1k
Sameer Agnihotri Canada 29 1.9k 2.2× 1.0k 1.4× 443 0.8× 1.3k 2.3× 237 0.5× 74 3.2k
Gerda Ricken Austria 24 514 0.6× 585 0.8× 858 1.5× 166 0.3× 393 0.8× 55 2.1k
Leomar Y. Ballester United States 29 752 0.9× 818 1.2× 273 0.5× 449 0.8× 133 0.3× 108 1.9k
Norman L. Lehman United States 30 1.1k 1.3× 613 0.9× 487 0.8× 285 0.5× 163 0.3× 73 2.4k
Yohei Mineharu Japan 29 507 0.6× 413 0.6× 281 0.5× 180 0.3× 302 0.6× 128 2.4k

Countries citing papers authored by Sheng Han

Since Specialization
Citations

This map shows the geographic impact of Sheng Han's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sheng Han with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sheng Han more than expected).

Fields of papers citing papers by Sheng Han

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sheng Han. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sheng Han. The network helps show where Sheng Han may publish in the future.

Co-authorship network of co-authors of Sheng Han

This figure shows the co-authorship network connecting the top 25 collaborators of Sheng Han. A scholar is included among the top collaborators of Sheng Han based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sheng Han. Sheng Han is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tian, Guofeng, et al.. (2025). Phenotypic variations in glioma stem cells: regulatory mechanisms and implications for therapeutic strategies. Journal of Translational Medicine. 23(1). 984–984.
2.
Han, Sheng, et al.. (2024). An NFAT1-C3a-C3aR Positive Feedback Loop in Tumor-Associated Macrophages Promotes a Glioma Stem Cell Malignant Phenotype. Cancer Immunology Research. 12(3). 363–376. 14 indexed citations
3.
Yang, Hui, et al.. (2024). Cost-effectiveness of Azvudine for High-risk Outpatients with Mild-to-moderate Coronavirus Disease 2019 in China. Clinical Therapeutics. 46(9). e1–e5. 3 indexed citations
4.
5.
Wang, Hang, Tingting Liu, Sheng Han, et al.. (2023). Integrated analysis identifies microRNA‐188‐5p as a suppressor of AKT/mTOR pathway in renal cancer. Cancer Science. 114(8). 3128–3143. 2 indexed citations
6.
Hou, Ana, et al.. (2023). NFAT signaling dysregulation in cancer: Emerging roles in cancer stem cells. Biomedicine & Pharmacotherapy. 165. 115167–115167. 17 indexed citations
7.
Li, Longjie, et al.. (2023). PD-L1 and tumor-infiltrating CD8+ lymphocytes are correlated with clinical characteristics in pediatric and adolescent pituitary adenomas. Frontiers in Endocrinology. 14. 1151714–1151714. 7 indexed citations
8.
9.
Wang, Xiaoliang, Li Zhang, Yang Jiang, et al.. (2021). MCM8 is regulated by EGFR signaling and promotes the growth of glioma stem cells through its interaction with DNA-replication-initiating factors. Oncogene. 40(27). 4615–4624. 13 indexed citations
10.
Jiang, Yang, Run Wang, Di Zhang, et al.. (2019). NFAT1-Mediated Regulation of NDEL1 Promotes Growth and Invasion of Glioma Stem-like Cells. Cancer Research. 79(10). 2593–2603. 36 indexed citations
11.
Zhang, Li, Yang Jiang, Di Zhang, et al.. (2019). MTBP regulates cell survival and therapeutic sensitivity in TP53 wildtype glioblastomas. Theranostics. 9(20). 6019–6030. 17 indexed citations
12.
Zhang, Chuanbao, Wen Cheng, Xiufang Ren, et al.. (2017). Tumor Purity as an Underlying Key Factor in Glioma. Clinical Cancer Research. 23(20). 6279–6291. 276 indexed citations
13.
Jiang, Yang, Sheng Han, Wen Cheng, Zixun Wang, & Anhua Wu. (2017). NFAT1-regulated IL6 signalling contributes to aggressive phenotypes of glioma. Cell Communication and Signaling. 15(1). 54–54. 50 indexed citations
14.
Han, Sheng, et al.. (2017). Lithium enhances the antitumour effect of temozolomide against TP53 wild-type glioblastoma cells via NFAT1/FasL signalling. British Journal of Cancer. 116(10). 1302–1311. 23 indexed citations
15.
Cheng, Wen, Xiufang Ren, Chuanbao Zhang, et al.. (2016). Gene Expression Profiling Stratifies IDH1-Mutant Glioma with Distinct Prognoses. Molecular Neurobiology. 54(8). 5996–6005. 22 indexed citations
16.
Han, Sheng, Jinyun Dong, Y Liu, et al.. (2014). Tumour-infiltrating CD4+ and CD8+ lymphocytes as predictors of clinical outcome in glioma. British Journal of Cancer. 110(10). 2560–2568. 274 indexed citations
17.
Han, Sheng, Zixun Wang, Yunjie Wang, & Anhua Wu. (2013). Transcerebellomedullary fissure approach to lesions of the fourth ventricle: less is more?. Acta Neurochirurgica. 155(6). 1011–1016. 32 indexed citations
18.
Han, Sheng, et al.. (2013). PMA and Ionomycin Induce Glioblastoma Cell Death: Activation-Induced Cell-Death-Like Phenomena Occur in Glioma Cells. PLoS ONE. 8(10). e76717–e76717. 21 indexed citations
19.
Jeong, Jaeseung, et al.. (2003). The effect of alpha entrainment stimulation on nonlinear dynamics of the EEG. Clinical Neurophysiology. 200(100). 1167–1368. 1 indexed citations
20.
Xing, Jun-Ling, San-Jue Hu, Hui Xu, Sheng Han, & Yehong Wan. (2001). Subthreshold membrane oscillations underlying integer multiples firing from injured sensory neurons. Neuroreport. 12(6). 1311–1313. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Wiesława Grajkowska Breakdown of academic impact, for papers by Wenbin Ma Breakdown of academic impact, for papers by Alessandra Pattarozzi Breakdown of academic impact, for papers by Juxiang Chen Breakdown of academic impact, for papers by Helle Broholm Breakdown of academic impact, for papers by Sameer Agnihotri Breakdown of academic impact, for papers by Gerda Ricken Breakdown of academic impact, for papers by Leomar Y. Ballester Breakdown of academic impact, for papers by Norman L. Lehman Breakdown of academic impact, for papers by Yohei Mineharu
Rankless by CCL
2026